PHOX2B inhibitors refer to a class of chemical compounds that are designed to specifically target and inhibit the activity of the PHOX2B gene, a transcription factor involved in the regulation of various genes responsible for the development and function of the autonomic nervous system. These inhibitors are primarily investigated and developed within the realm of molecular biology and genetic research to better understand the role of PHOX2B in cellular processes.
PHOX2B inhibitors typically fall under the category of small molecules, which are compounds with low molecular weight that can penetrate cells and interact with biological molecules. These inhibitors are carefully designed to disrupt the normal function of PHOX2B by binding to it or its associated proteins, thus preventing its transcriptional activity. In some cases, they may modulate PHOX2B's gene expression indirectly through epigenetic modifications, such as DNA methylation or histone acetylation. The goal of studying PHOX2B inhibitors is to gain insights into the molecular mechanisms by which PHOX2B influences neural development and identify new avenues for research in the field of neurobiology and genetics. Researchers use these inhibitors to explore the downstream effects of PHOX2B inhibition, which can help elucidate its role in cellular differentiation, neuronal development, and gene regulation. By understanding the precise interactions and pathways affected by PHOX2B inhibitors, scientists aim to contribute to the broader understanding of neural development and uncover new strategies for manipulating gene expression in a controlled laboratory setting.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
CX-4945 | 1009820-21-6 | sc-364475 sc-364475A | 2 mg 50 mg | $183.00 $800.00 | 9 | |
CX-4945 is a protein kinase CK2 inhibitor. While it primarily targets CK2, it has been studied in the context of neuroblastoma, where it may indirectly affect PHOX2B. | ||||||
RO-3306 | 872573-93-8 | sc-358700 sc-358700A sc-358700B | 1 mg 5 mg 25 mg | $66.00 $163.00 $326.00 | 37 | |
RO-3306 is a potent inhibitor of cyclin-dependent kinase 1 (CDK1). It may indirectly affect PHOX2B through cell cycle regulation. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 is a bromodomain and extraterminal (BET) protein inhibitor. It may affect PHOX2B expression through epigenetic regulation. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
Olaparib is a poly(ADP-ribose) polymerase (PARP) inhibitor. It may impact PHOX2B indirectly by affecting DNA repair pathways. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
I-BET151 is another BET protein inhibitor, like JQ1, that could potentially influence PHOX2B expression. | ||||||